Where Will Allovir Inc (ALVR) Stock Go Next After It Is Up 15.38% in a Week?

Allovir Inc (ALVR) stock is higher by 15.38% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Allovir Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ALVR!

See Full ALVR Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ALVR Stock Today?

Allovir Inc (ALVR) stock is trading at $1.80 as of 12:53 PM on Wednesday, Nov 29, an increase of $0.16, or 10.12% from the previous closing price of $1.63. The stock has traded between $1.64 and $1.83 so far today. Volume today is 595,269 compared to average volume of 782,306. To see InvestorsObserver's Sentiment Score for Allovir Inc click here.

More About Allovir Inc

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Click Here to get the full Stock Report for Allovir Inc stock.